Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy.
Jinghua JiaoHonghua YuLitong YaoLihua LiXiaohong YangLei LiuPublished in: Journal of inflammation research (2021)
The microbiome has become a hot issue in recent years. The composition, modification, alteration, and disturbance of gut microbiota were found to influence important physiological processes, including energy metabolism and microenvironmental homeostasis, and lead to various diseases, including obesity, type 2 diabetes mellitus and chronic kidney disease. Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus and one of the leading causes of blindness and vision impairment. The underlying mechanisms in DR pathogenesis remain limited. Recently, important insights have been made regarding possible connections between gut microbiome dysbiosis and ocular disease including DR, uveitis, glaucoma, and age-related macular degeneration, and the concept of a "microbiota-gut-retina axis" has been put forward. Hence, we reviewed current understanding of the relationship between DR and gut microbiota. We summarized potential pathophysiological mechanisms that contribute to the role of the gut microbiota on DR, including hyperglycemia, anti-diabetes drugs, microbial metabolites, and inflammatory properties. We aimed to find novel effective therapeutic options to prevent the onset and development of DR.
Keyphrases
- diabetic retinopathy
- editorial comment
- optical coherence tomography
- chronic kidney disease
- type diabetes
- glycemic control
- age related macular degeneration
- insulin resistance
- metabolic syndrome
- weight loss
- microbial community
- end stage renal disease
- body mass index
- weight gain
- rheumatoid arthritis
- skeletal muscle
- ankylosing spondylitis
- juvenile idiopathic arthritis
- drug induced
- climate change
- disease activity
- diabetic rats